rs10263935
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_153033.5(KCTD7):c.144+1833G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.506 in 152,032 control chromosomes in the GnomAD database, including 20,429 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.51 ( 20429 hom., cov: 33)
Consequence
KCTD7
NM_153033.5 intron
NM_153033.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.135
Publications
22 publications found
Genes affected
KCTD7 (HGNC:21957): (potassium channel tetramerization domain containing 7) This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011]
KCTD7 Gene-Disease associations (from GenCC):
- progressive myoclonic epilepsy type 3Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- progressive myoclonus epilepsyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.653 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD7 | NM_153033.5 | c.144+1833G>A | intron_variant | Intron 1 of 3 | ENST00000639828.2 | NP_694578.1 | ||
KCTD7 | NM_001167961.2 | c.144+1833G>A | intron_variant | Intron 1 of 4 | NP_001161433.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.506 AC: 76870AN: 151916Hom.: 20400 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
76870
AN:
151916
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.506 AC: 76945AN: 152032Hom.: 20429 Cov.: 33 AF XY: 0.500 AC XY: 37141AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
76945
AN:
152032
Hom.:
Cov.:
33
AF XY:
AC XY:
37141
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
27353
AN:
41458
American (AMR)
AF:
AC:
7393
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1311
AN:
3472
East Asian (EAS)
AF:
AC:
1336
AN:
5178
South Asian (SAS)
AF:
AC:
1742
AN:
4826
European-Finnish (FIN)
AF:
AC:
4217
AN:
10548
Middle Eastern (MID)
AF:
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32145
AN:
67972
Other (OTH)
AF:
AC:
1012
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1914
3828
5742
7656
9570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1112
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.